Latest news
Dispatch Bio Announces First Patient Dosed in Phase 1 Study of DISP-10, a Novel Investigational Immunotherapy, in Advanced Gastrointestinal (GI) Cancers - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 12:00:00 GMTOak Hill Bio Announces Dosing of First Participant in - GlobeNewswireGlobeNewswire · Tue, 28 Jul 2026 12:00:00 GMT